Elyse Foster

Author PubWeight™ 219.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005 46.32
2 Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009 12.44
3 Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 2003 11.88
4 Recommendations for chamber quantification. Eur J Echocardiogr 2006 11.39
5 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2010 7.54
6 Percutaneous repair or surgery for mitral regurgitation. N Engl J Med 2011 5.78
7 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010 4.56
8 Survival with cardiac-resynchronization therapy in mild heart failure. N Engl J Med 2014 3.80
9 Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol 2009 3.26
10 Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 2004 3.22
11 Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol 2012 3.01
12 Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves, developed in conjunction with the American College of Cardiology Cardiovascular Imaging Committee, Cardiac Imaging Committee of the American Heart Association, the European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography and the Canadian Society of Echocardiography, endorsed by the American College of Cardiology Foundation, American Heart Association, European Association of Echocardiography, a registered branch of the European Society of Cardiology, the Japanese Society of Echocardiography, and Canadian Society of Echocardiography. J Am Soc Echocardiogr 2009 3.00
13 Cardiac resynchronization therapy for the treatment of heart failure in patients with intraventricular conduction delay and malignant ventricular tachyarrhythmias. J Am Coll Cardiol 2003 2.91
14 Cardiac resynchronization therapy is more effective in women than in men: the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) trial. J Am Coll Cardiol 2011 2.84
15 Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2012 2.78
16 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2010 2.58
17 Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol 2005 2.56
18 Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke 2004 2.37
19 Acute neurocardiogenic injury after subarachnoid hemorrhage. Circulation 2005 2.36
20 Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study. J Am Coll Cardiol 2012 2.31
21 Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation 2013 2.24
22 The alpha(1A/C)- and alpha(1B)-adrenergic receptors are required for physiological cardiac hypertrophy in the double-knockout mouse. J Clin Invest 2003 2.10
23 Predictors of response to cardiac resynchronization therapy in the Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy (MADIT-CRT). Circulation 2011 2.08
24 Predictors of left ventricular regional wall motion abnormalities after subarachnoid hemorrhage. Neurocrit Care 2006 2.05
25 Reverse remodeling and the risk of ventricular tachyarrhythmias in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy). J Am Coll Cardiol 2011 1.95
26 Septal to posterior wall motion delay fails to predict reverse remodeling or clinical improvement in patients undergoing cardiac resynchronization therapy. J Am Coll Cardiol 2005 1.90
27 Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy: a randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing. Circulation 2007 1.88
28 Alpha1-adrenergic receptors prevent a maladaptive cardiac response to pressure overload. J Clin Invest 2006 1.81
29 Clinical relevance of retrograde inferior vena cava or hepatic vein opacification during contrast-enhanced CT. AJR Am J Roentgenol 2004 1.73
30 A longitudinal study of left ventricular function and structure from CKD to ESRD: the CRIC study. Clin J Am Soc Nephrol 2013 1.72
31 Assessment of systolic dyssynchrony for cardiac resynchronization therapy is not clinically useful. Circulation 2011 1.67
32 Best practices in managing transition to adulthood for adolescents with congenital heart disease: the transition process and medical and psychosocial issues: a scientific statement from the American Heart Association. Circulation 2011 1.64
33 Effects of resynchronization therapy on cardiac function in pacemaker patients "upgraded" to biventricular devices. J Cardiovasc Electrophysiol 2004 1.63
34 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol 2013 1.62
35 Relationship between accurate auscultation of a clinically useful third heart sound and level of experience. Arch Intern Med 2006 1.61
36 Plasma B-type natriuretic peptide levels are associated with early cardiac dysfunction after subarachnoid hemorrhage. Stroke 2005 1.61
37 Relationship between the magnitude of reduction in mitral regurgitation severity and left ventricular and left atrial reverse remodeling after MitraClip therapy. Circulation 2013 1.58
38 The EVEREST II Trial: design and rationale for a randomized study of the evalve mitraclip system compared with mitral valve surgery for mitral regurgitation. Am Heart J 2010 1.53
39 ACC/AHA/AAP recommendations for training in pediatric cardiology. Pediatrics 2005 1.46
40 ACC/AHA clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence. J Am Coll Cardiol 2003 1.42
41 Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography. Am J Physiol Heart Circ Physiol 2005 1.42
42 Is MRI the preferred method for evaluating right ventricular size and function in patients with congenital heart disease?: MRI is not the preferred method for evaluating right ventricular size and function in patients with congenital heart disease. Circ Cardiovasc Imaging 2014 1.38
43 Validation of the wall motion score and myocardial performance indexes as novel techniques to assess cardiac function in mice after myocardial infarction. Am J Physiol Heart Circ Physiol 2006 1.33
44 Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events. BMC Fam Pract 2008 1.32
45 Prospective analysis of prevalence, distribution, and rate of recovery of left ventricular systolic dysfunction in patients with subarachnoid hemorrhage. J Neurosurg 2006 1.32
46 Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: multicenter automatic defibrillator implantation trial: cardiac resynchronization therapy. Circulation 2010 1.31
47 Effects of long-term biventricular stimulation for resynchronization on echocardiographic measures of remodeling. Circulation 2002 1.30
48 Imaging biomarkers of aortic disease: increased growth rates with eccentric systolic flow. J Am Coll Cardiol 2012 1.20
49 Effects of intravenous levosimendan on human coronary vasomotor regulation, left ventricular wall stress, and myocardial oxygen uptake. Circulation 2005 1.15
50 Pulmonary dead space fraction and pulmonary artery systolic pressure as early predictors of clinical outcome in acute lung injury. Chest 2007 1.10
51 American College of Cardiology/American Heart Association clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians--American Society of Internal Medicine Task Force on Clinical Competence. Circulation 2003 1.09
52 High-sensitivity C-reactive protein and parameters of left ventricular dysfunction. J Card Fail 2006 1.09
53 Multicenter automatic defibrillator implantation trial-cardiac resynchronization therapy (MADIT-CRT): design and clinical protocol. Ann Noninvasive Electrocardiol 2005 1.08
54 Mortality associated with adult congenital heart disease: Trends in the US population from 1979 to 2005. Am Heart J 2009 1.08
55 Anomalous origin of the left coronary artery from the pulmonary artery: a case series and brief review. Congenit Heart Dis 2006 1.06
56 The acute hemodynamic effects of MitraClip therapy. J Am Coll Cardiol 2011 1.06
57 Surgical revision after percutaneous mitral repair with the MitraClip device. Ann Thorac Surg 2010 1.05
58 Dyssynchrony, contractile function, and response to cardiac resynchronization therapy. Circ Heart Fail 2011 1.05
59 Repeat transseptal catheterization after ablation for atrial fibrillation. J Cardiovasc Electrophysiol 2006 1.05
60 The clinical pharmacology of intranasal l-methamphetamine. BMC Clin Pharmacol 2008 1.04
61 Endovascular edge-to-edge mitral valve repair: short-term results in a porcine model. Circulation 2003 1.04
62 Left ventricular pressure-volume relationship in conscious mice. Am J Physiol Heart Circ Physiol 2006 1.02
63 Working group 2: How to encourage more women to choose a career in cardiology. J Am Coll Cardiol 2004 1.01
64 Accuracy of Doppler-estimated pulmonary vascular resistance in patients before liver transplantation. Am J Cardiol 2008 0.98
65 Effect of percutaneous mitral repair with the MitraClip device on mitral valve area and gradient. EuroIntervention 2009 0.96
66 Association between phonocardiographic third and fourth heart sounds and objective measures of left ventricular function. JAMA 2005 0.95
67 New technique for measurement of left ventricular pressure in conscious mice. Am J Physiol Heart Circ Physiol 2003 0.94
68 Age and aneurysm position predict patterns of left ventricular dysfunction after subarachnoid hemorrhage. J Am Soc Echocardiogr 2005 0.94
69 Survey results: a decade of change in professional life in cardiology: a 2008 report of the ACC women in cardiology council. J Am Coll Cardiol 2008 0.94
70 Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response. Circulation 2004 0.94
71 Prevalence and implications of diastolic dysfunction after subarachnoid hemorrhage. Neurocrit Care 2005 0.93
72 Cardiac resynchronization therapy reduces left atrial volume and the risk of atrial tachyarrhythmias in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy). J Am Coll Cardiol 2011 0.92
73 Closure of a para-valvular aortic leak: with the use of 2 AMPLATZER devices and real-time 2- and 3-dimensional transesophageal echocardiography. Tex Heart Inst J 2011 0.92
74 Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial. Eur Heart J 2011 0.92
75 Diagnostic characteristics of combining phonocardiographic third heart sound and systolic time intervals for the prediction of left ventricular dysfunction. J Card Fail 2007 0.91
76 Post-stenotic dilation: evaluation of ascending aortic dilation with 4D flow MR imaging. Int J Cardiol 2011 0.91
77 Congenital heart disease in the older adult: a scientific statement from the American Heart Association. Circulation 2015 0.91
78 Echocardiographic guidance and assessment of percutaneous repair for mitral regurgitation with the Evalve MitraClip: lessons learned from EVEREST I. J Am Soc Echocardiogr 2007 0.90
79 Epinephrine is required for normal cardiovascular responses to stress in the phenylethanolamine N-methyltransferase knockout mouse. Circulation 2007 0.89
80 Pulmonary insufficiency is the nexus of late complications in tetralogy of Fallot. Curr Cardiol Rep 2007 0.89
81 ACC/AHA clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on clinical competence. J Am Soc Echocardiogr 2003 0.89
82 Impaired regional left ventricular strain after repair of tetralogy of Fallot. J Magn Reson Imaging 2011 0.88
83 EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure. J Thorac Cardiovasc Surg 2012 0.88
84 Echocardiographic predictors of single versus dual MitraClip device implantation and long-term reduction of mitral regurgitation after percutaneous repair. Catheter Cardiovasc Interv 2013 0.86
85 Short-term and long-term success of electrical cardioversion in atrial fibrillation in managed care system. Int Arch Med 2009 0.84
86 Association of the fourth heart sound with increased left ventricular end-diastolic stiffness. J Card Fail 2008 0.83
87 Clinical factors and echocardiographic techniques related to the presence, size, and location of acoustic windows for leadless cardiac pacing. Europace 2011 0.83
88 Anticoagulation during pregnancy. Curr Womens Health Rep 2002 0.81
89 Isolated bundle branch block and left ventricular dysfunction. J Card Fail 2003 0.81
90 Demonstration of coronary artery flow using transthoracic Doppler echocardiography. J Am Soc Echocardiogr 2004 0.81
91 Correlation between right ventricular indices and clinical improvement in epoprostenol treated pulmonary hypertension patients. Echocardiography 2005 0.81
92 Clinical significance of elevated B-type natriuretic peptide in patients with acute lung injury with or without right ventricular dilatation: an observational cohort study. Ann Intensive Care 2011 0.80
93 Harmonic imaging improves sensitivity at the expense of specificity in the detection of patent foramen ovale. Echocardiography 2004 0.80
94 CMR assessment of right ventricular function in patients with combined pulmonary stenosis and insufficiency after correction of tetralogy of Fallot. Acta Radiol 2013 0.79
95 Prospective validation of an echocardiographic index for determining the severity of chronic mitral regurgitation. Am J Cardiol 2002 0.79
96 Obese patients have lower B-type and atrial natriuretic peptide levels compared with nonobese. Congest Heart Fail 2006 0.79
97 Performance of phonoelectrocardiographic left ventricular systolic time intervals and B-type natriuretic peptide levels in the diagnosis of left ventricular dysfunction. Ann Noninvasive Electrocardiol 2007 0.79
98 Echocardiographic predictors of change in left ventricular diastolic pressure in heart failure patients receiving nesiritide. Echocardiography 2008 0.79
99 Mitral valve hemodynamic effects of percutaneous edge-to-edge repair with the MitraClip device for mitral regurgitation. Catheter Cardiovasc Interv 2006 0.78
100 Right ventricular function, pulmonary pressure estimation, and clinical outcomes in cardiac resynchronization therapy. Circ Heart Fail 2013 0.78
101 ACCF/AHA/AAP recommendations for training in pediatric cardiology. A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence (ACC/AHA/AAP Writing Committee to Develop Training Recommendations for Pediatric Cardiology). Circulation 2005 0.78
102 New untwist on diastole: what goes around comes back. Circulation 2006 0.77
103 HIV infection is not associated with echocardiographic signs of cardiomyopathy or pulmonary hypertension among pregnant Ugandan women. Int J Cardiol 2010 0.77
104 Effects of atrial fibrillation on treatment of mitral regurgitation in the EVEREST II (Endovascular Valve Edge-to-Edge Repair Study) randomized trial. J Am Coll Cardiol 2012 0.77
105 Sudden death due to nonarrhythmic cause in a patient with L-TGA. Ann Noninvasive Electrocardiol 2013 0.76
106 ACCF/AHA/AAP recommendations for training in pediatric cardiology. Task force 6: training in transition of adolescent care and care of the adult with congenital heart disease. J Am Coll Cardiol 2005 0.76
107 Rethinking mitral valve surgery during the golden years. Circulation 2013 0.75
108 Mitral regurgitation and pulmonary edema. J Gen Intern Med 2011 0.75
109 Response to Geva. Circ Cardiovasc Imaging 2014 0.75
110 Masses of the heart: perfusing the "good" from the bad. J Am Coll Cardiol 2004 0.75
111 Clinical problem-solving. A missed connection. N Engl J Med 2012 0.75
112 Physiology of the third heart sound: novel insights from tissue Doppler imaging. J Am Soc Echocardiogr 2007 0.75
113 Acute effects of withdrawal of cardiac resynchronization therapy on left and right ventricular function, dyssynchrony, and contractile function in patients with New York Heart Association functional class I/II heart failure: MADIT-CRT. J Card Fail 2013 0.75
114 Congenital heart disease in the adult. Int Anesthesiol Clin 2012 0.75
115 AVJ-514 Trial - Baseline Characteristics and 30-Day Outcomes Following MitraClip(®) Treatment in a Japanese Cohort. Circ J 2017 0.75
116 A comparison of cardiac resynchronization by sequential biventricular pacing and left ventricular pacing to simultaneous biventricular pacing: rationale and design of the DECREASE-HF clinical trial. J Card Fail 2005 0.75
117 Echocardiographic evaluation in transposition of the great arteries in the adult. Echocardiography 2014 0.75
118 Clinical correlates and mortality of hemodynamically significant tricuspid regurgitation. J Heart Valve Dis 2004 0.75
119 Is PA-PWRmax truly a preload-independent index of myocardial contractility in anesthetized humans? Cardiology 2004 0.75